RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.040
+0.010 (0.97%)
Apr 28, 2026, 4:00 PM EDT - Market closed
RedHill Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -0.43 | -8.27 | 23.92 | -71.67 | -97.74 | |
| Depreciation & Amortization | 0.41 | 0.62 | 1.99 | 8.15 | 18.15 | |
| Loss (Gain) on Equity Investments | 0.03 | - | - | - | - | |
| Stock-Based Compensation | 0.46 | 0.67 | 1.65 | 5.68 | 10.21 | |
| Other Operating Activities | -8.15 | -4.44 | -47.75 | 20.65 | 5.49 | |
| Change in Accounts Receivable | 2.26 | 0.05 | 31.93 | -2.85 | -3.02 | |
| Change in Inventory | -0.38 | 0.74 | 2.39 | 3.8 | -8.29 | |
| Change in Accounts Payable | -0.44 | -2.11 | -0.95 | -7.43 | 0.11 | |
| Change in Other Net Operating Assets | -3.42 | 3.37 | -48.98 | 14.49 | 10.04 | |
| Operating Cash Flow | -7.19 | -9.37 | -35.82 | -29.19 | -65.05 | |
| Capital Expenditures | -0.01 | -0.01 | -0.01 | -0.2 | -0.12 | |
| Investment in Securities | 1.7 | - | 0.02 | 8.5 | -8.03 | |
| Other Investing Activities | -1.7 | - | - | - | - | |
| Investing Cash Flow | -0.01 | -0.01 | 0 | 8.3 | -8.14 | |
| Long-Term Debt Repaid | -0.45 | -0.64 | -1.18 | -1.48 | -1.68 | |
| Net Debt Issued (Repaid) | -0.45 | -0.64 | -1.18 | -1.48 | -1.68 | |
| Issuance of Common Stock | 7.76 | 8.26 | 13.96 | 23.81 | 82.54 | |
| Other Financing Activities | - | 0.79 | 8.66 | -10.88 | -7.4 | |
| Financing Cash Flow | 7.32 | 8.42 | 21.44 | 11.45 | 73.46 | |
| Foreign Exchange Rate Adjustments | -0 | 0.01 | -0.02 | -0.08 | -0.1 | |
| Net Cash Flow | 0.12 | -0.95 | -14.4 | -9.51 | 0.18 | |
| Free Cash Flow | -7.2 | -9.38 | -35.83 | -29.38 | -65.16 | |
| Free Cash Flow Margin | -2516.08% | -116.60% | -548.71% | -47.55% | -75.98% | |
| Free Cash Flow Per Share | - | -7.61 | -138.28 | -476.76 | -1400.52 | |
| Cash Interest Paid | - | 0.06 | 0.37 | 8.18 | 11.28 | |
| Levered Free Cash Flow | -3.53 | -0.54 | -17.49 | -52.39 | -34.94 | |
| Unlevered Free Cash Flow | -2.62 | -0.5 | -17.26 | -26.56 | -24.58 | |
| Change in Working Capital | -1.97 | 2.05 | -15.62 | 8.01 | -1.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.